We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

TGFB1 rs2241715: Understanding Its Link to Childhood Asthma

rs2241715
Trait
Moderate evidenceGene: TGFB1

The rs2241715 variant is a single nucleotide polymorphism located within the TGFB1 gene. It has been identified in scientific literature as having a statistical association with childhood asthma susceptibility in specific populations.

What each genotype means

C/CLower attention

Typical TGFB1 expression

This genotype represents the most common form of the TGFB1 gene variant. Research into this specific marker has explored its potential role in immune system regulation and childhood asthma susceptibility, though findings remain complex and can vary significantly between different ancestral populations.

This is the most frequently observed genotype across most global populations.

C/TModerate attention

Varied TGFB1 expression

Carrying one copy of the T allele means you have a heterozygous genotype for this variant. Some studies have investigated whether this variant influences TGF-beta1 protein levels or asthma-related traits, but results are mixed and often depend on environmental factors and specific ethnic backgrounds.

This genotype is found at varying frequencies globally, appearing in a significant portion of the population.

T/TModerate attention

Alternative TGFB1 expression

This genotype represents the homozygous alternative form of the variant. While some research has associated this variant with immune-related phenotypes or asthma susceptibility in specific cohorts, the evidence is not universal and may not apply to all individuals or populations.

This is the least common of the three genotypes in most studied populations.

What is rs2241715?

The variant rs2241715 is a single nucleotide polymorphism (SNP) located within the TGFB1 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found on chromosome 19, where the TGFB1 gene resides. Researchers study such variants to understand how minor differences in our genetic code might contribute to complex traits or disease susceptibility. Because rs2241715 is a common variant, it is frequently included in genetic association studies that aim to map the relationship between specific DNA locations and health-related outcomes. It is important to note that the presence of a specific SNP does not determine a health outcome on its own; rather, it is one of many factors—including other genetic markers and environmental influences—that researchers investigate to build a clearer picture of human biology.

The Role of the TGFB1 Gene

The TGFB1 gene provides instructions for making a protein called transforming growth factor beta-1. This protein is a cytokine, a type of signaling molecule that plays a critical role in regulating cell growth, proliferation, differentiation, and apoptosis. TGF-beta1 is particularly well-known for its involvement in the immune system and the body's inflammatory response. It helps control the activity of various immune cells and is essential for tissue repair and the maintenance of the extracellular matrix. Because of its central role in inflammation and tissue remodeling, researchers have long hypothesized that variations in the TGFB1 gene could influence conditions characterized by airway inflammation, such as asthma. By modulating how the body responds to environmental triggers, the TGFB1 protein may influence the development or severity of respiratory symptoms in susceptible individuals.

Research and Evidence Strength

The association between rs2241715 and childhood asthma is supported by moderate evidence, primarily derived from candidate gene studies. For instance, research published in the Journal of Allergy and Clinical Immunology has highlighted this SNP as showing significant association with asthma susceptibility, particularly in specific populations such as those of Mexican ancestry. While these findings are statistically significant within the context of those studies, it is important to recognize that genetic associations can vary widely across different ethnic and ancestral groups. Some studies have reported conflicting results or failed to replicate initial findings, which is common in the study of complex, polygenic traits like asthma. Consequently, while rs2241715 is a recognized marker in the literature, it is considered one of many potential contributors to asthma risk rather than a definitive diagnostic indicator.

Population Frequency

The rs2241715 variant is considered a common SNP, meaning it is found at a relatively high frequency across many global populations. Genetic databases indicate that the alleles for this variant are widely distributed, though the exact frequency of each genotype can fluctuate depending on the ancestral background of the population being studied. Because it is common, it is easily detected in large-scale genetic screenings. However, the clinical relevance of this frequency is nuanced; a variant being 'common' simply means it is a standard part of human genetic diversity, not that it necessarily confers a high risk of disease. Researchers use this high frequency to their advantage, as it allows for robust statistical analysis when comparing groups with and without specific health conditions, provided the study design accounts for population stratification.

What This Information Means for You

Understanding your genetic variants can be an educational experience, but it is vital to interpret this information within the correct context. The association between rs2241715 and asthma is a statistical observation made at the population level, not a medical diagnosis for an individual. Many factors, including genetics, environment, lifestyle, and early-life exposures, interact to influence the development of asthma. If you are concerned about asthma or respiratory health, you should consult with a healthcare professional, such as a pediatrician or an allergist. They can provide a clinical assessment based on your symptoms, medical history, and physical examinations. Never use genetic information to make decisions about medication or treatment plans without first discussing them with your clinician or pharmacist, as they are the only ones qualified to provide personalized medical advice.

How common is this variant?

The rs2241715 variant is common across global populations, with its specific genotype frequencies varying by ancestral background.

Frequently asked questions

Does having the rs2241715 variant mean I will develop asthma?

No. Genetic variants like rs2241715 are associated with statistical trends in populations, not individual outcomes. Asthma is a complex condition influenced by many genetic and environmental factors.

Can I use this SNP to diagnose asthma?

No. Genetic testing for common variants is not a diagnostic tool for asthma. A diagnosis should only be made by a healthcare provider based on clinical symptoms and lung function tests.

Should I change my asthma medication based on my genotype?

No. You should never change your medication or treatment plan based on genetic information without consulting your doctor or pharmacist. They are responsible for managing your care.

Why do different studies show different results for this variant?

Genetic associations can vary due to differences in study design, the ancestral background of the participants, and environmental factors. This is common in research on complex diseases.

Sources & further reading

Educational information only, last refreshed 10/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs2241715?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in TGFB1